Business
Why Monte Rosa Therapeutics Inc (NASDAQ: GLUE) Stock Should Not Be Taken For Granted By Investors In 2024
In the last trading session, 5.94 million shares of the Monte Rosa Therapeutics Inc (NASDAQ:GLUE) were traded, and its beta was 1.43. Most recently the
